Inclusive
7078
Chordia Therapeutics
190A
Cube
7112
Kufu Company Holdings
4376
Btm
5247
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 1.46%798.37M | 24.60%786.87M | 11.50%631.5M | 3.09%566.35M | 42.23%549.4M | 7.47%386.26M | 311.04%359.42M | 295.31%87.44M | -107.96%-44.77M | 107.96%562.77M |
Net profit before non-cash adjustment | -1.93%573.65M | -4.08%584.96M | -2.67%609.83M | 26.83%626.53M | 38.30%493.99M | 16.87%357.2M | 58.23%305.65M | -30.87%193.17M | -14.63%279.42M | 30.91%327.32M |
Total adjustment of non-cash items | 23.50%219.29M | 510.30%177.56M | 138.03%29.09M | -323.56%-76.51M | -11.04%34.22M | -20.87%38.47M | -37.44%48.61M | 859.16%77.71M | -84.84%8.1M | 104.87%53.43M |
-Depreciation and amortization | 3.02%179.94M | 74.28%174.66M | -9.30%100.22M | 34.31%110.5M | 18.83%82.27M | 18.98%69.23M | -7.45%58.19M | 22.01%62.87M | 1.72%51.53M | -0.86%50.66M |
-Reversal of impairment losses recognized in profit and loss | 1,377.80%41.6M | --2.82M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -38.87%5.12M | 142.89%8.38M |
-Share of associates | 400.31%6.82M | 32.04%-2.27M | 75.96%-3.34M | 41.26%-13.91M | 8.31%-23.68M | -251.37%-25.82M | 38.54%-7.35M | 44.32%-11.96M | 23.44%-21.48M | -10.43%-28.05M |
-Disposal profit | 43,450.00%5.23M | 100.02%12K | 63.37%-54.76M | ---149.48M | --0 | 365.96%2.66M | -97.89%570K | 1,824.07%27.01M | 196.16%1.4M | -141.55%-1.46M |
-Pension and employee benefit expenses | --0 | --13.28M | --0 | ---- | ---- | ---- | ---- | ---- | 9.96%6.1M | --5.55M |
-Other non-cash items | -30.71%-14.29M | 16.04%-10.93M | 44.85%-13.02M | 3.11%-23.61M | -220.82%-24.37M | -171.90%-7.6M | -1,205.61%-2.79M | 99.38%-214K | -288.39%-34.58M | 11.91%18.35M |
Changes in working capital | -77.70%5.43M | 428.12%24.36M | -145.47%-7.42M | -22.95%16.33M | 325.32%21.19M | -282.44%-9.4M | 102.81%5.15M | 44.80%-183.44M | -282.55%-332.29M | 3,413.82%182.03M |
-Change in receivables | -211.85%-2.53M | 107.00%2.26M | -3,537.61%-32.3M | 92.10%-888K | 27.35%-11.24M | -49.60%-15.47M | -221.08%-10.34M | -53.41%8.54M | 156.02%18.33M | -1,037.11%-32.73M |
-Change in inventory | -95.03%39K | 198.13%785K | -16,100.00%-800K | -99.87%5K | 203.15%3.93M | -3,150.40%-3.81M | -82.34%125K | -62.76%708K | 173.68%1.9M | -86,100.00%-2.58M |
-Change in payables | -270.26%-1.79M | -79.38%1.05M | 156.86%5.09M | -243.40%-8.95M | 127.78%6.24M | 264.70%2.74M | 99.11%-1.66M | 45.44%-187.72M | -257.41%-344.05M | 9,888.18%218.57M |
-Provision for loans, leases and other losses | -52.09%9.71M | -1.61%20.26M | -21.27%20.59M | 17.52%26.16M | 211.53%22.26M | -58.06%7.14M | 179.49%17.04M | --6.1M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -30.54%-11.07M | -585.92%-8.48M | -221.04%-1.24M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -21K | |||||||||
Interest received (cash flow from operating activities) | 56.26%33.58M | 83.61%21.49M | 13.69%11.7M | -10.77%10.3M | 15.08%11.54M | 28.08%10.03M | -4.14%7.83M | 15.67%8.17M | 9.51%7.06M | 5.46%6.45M |
Tax refund paid | -46.13%-290.03M | 19.15%-198.48M | -12.07%-245.49M | -94.25%-219.05M | 24.23%-112.77M | -230.22%-148.83M | 42.05%-45.07M | 45.25%-77.77M | -38.97%-142.06M | -14.83%-102.23M |
Other operating cash inflow (outflow) | 99.99%-1K | -1,328,100.00%-13.28M | 1K | 0 | 0 | 0 | 0 | 0 | -1K | 0 |
Operating cash flow | -9.17%541.92M | 50.01%596.6M | 11.22%397.72M | -20.21%357.59M | 81.11%448.17M | -23.19%247.46M | 1,708.74%322.17M | 109.91%17.81M | -138.50%-179.77M | 148.79%466.99M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -467.03%-76.5M | -4.31%-13.49M | 84.15%-12.94M | -476.55%-81.63M | 85.24%-14.16M | -1,694.29%-95.91M | -47.65%-5.35M | 87.88%-3.62M | -618.25%-29.88M | 82.19%-4.16M |
Net intangibles purchase and sale | 43.16%-47.49M | -50.71%-83.54M | 12.06%-55.43M | 6.21%-63.03M | -17.43%-67.21M | -18.82%-57.23M | -1.49%-48.17M | 32.61%-47.46M | -97.14%-70.43M | -46.57%-35.72M |
Net business purchase and sale | --0 | -1,753.13%-581.81M | -111.30%-31.4M | --277.83M | ---- | ---- | ---55.62M | ---- | ---- | ---- |
Net investment product transactions | 167.14%39.26M | 70.45%-58.48M | -460.40%-197.86M | -561.55%-35.31M | 6.15%-5.34M | 0.00%-5.69M | -112.85%-5.69M | 141.01%44.24M | -292.61%-107.87M | 1,021.29%56.01M |
Net changes in other investments | -7,295.12%-6.06M | 96.74%-82K | -119.81%-2.52M | -51.93%12.7M | 1,102.27%26.43M | -94.08%2.2M | 394.67%37.1M | -73.57%7.5M | 2,484.62%28.38M | -101.19%-1.19M |
Investing cash flow | 87.69%-90.79M | -145.68%-737.4M | -371.48%-300.14M | 283.42%110.56M | 61.52%-60.28M | -101.53%-156.62M | -11,857.64%-77.72M | 100.37%661K | -1,304.21%-179.8M | -67.90%14.93M |
Financing cash flow | ||||||||||
Net common stock issuance | ---- | ---- | ---135K | --0 | ---85K | ---- | ---26K | ---- | -325.00%-119K | ---28K |
Cash dividends paid | 23.95%-133.99M | -61.82%-176.19M | -13.80%-108.88M | -29.20%-95.68M | -23.56%-74.05M | -0.06%-59.93M | -0.03%-59.9M | -0.05%-59.88M | -30.82%-59.86M | -29.69%-45.75M |
Net other fund-raising expenses | ---- | ---- | -100.01%-1K | --9.45M | ---- | ---- | --5.05M | ---- | ---- | ---- |
Financing cash flow | 23.95%-133.99M | -61.62%-176.19M | -26.43%-109.01M | -16.30%-86.23M | -23.70%-74.14M | -9.22%-59.93M | 8.36%-54.88M | 0.15%-59.88M | -31.00%-59.97M | -29.77%-45.78M |
Net cash flow | ||||||||||
Beginning cash position | -16.08%1.66B | -0.50%1.98B | 23.78%1.99B | 24.27%1.61B | 2.41%1.29B | 17.75%1.26B | -4.05%1.07B | -27.35%1.12B | 39.91%1.54B | 22.47%1.1B |
Current changes in cash | 200.05%317.14M | -2,671.82%-316.99M | -102.99%-11.44M | 21.73%381.92M | 915.25%313.75M | -83.70%30.9M | 557.82%189.58M | 90.13%-41.41M | -196.19%-419.54M | 119.23%436.14M |
Effect of exchange rate changes | 99.41%-6K | -170.66%-1.01M | 4,848.28%1.44M | 120.00%29K | 70.94%-145K | -179.59%-499K | 116.22%627K | -301.45%-3.87M | -139.39%-963K | -7.60%2.45M |
Cash adjustments other than cash changes | 50.00%-1K | -100.00%-2K | -200.00%-1K | 133.33%1K | ---3K | ---- | ---- | ---- | -400.00%-3K | 0.00%1K |
End cash Position | 19.11%1.98B | -16.08%1.66B | -0.50%1.98B | 23.78%1.99B | 24.27%1.61B | 2.41%1.29B | 17.75%1.26B | -4.05%1.07B | -27.35%1.12B | 39.91%1.54B |
Free cash flow | -16.34%417.93M | 51.68%499.57M | 55.78%329.35M | -42.36%211.42M | 288.87%366.8M | -64.80%94.33M | 905.49%267.96M | 88.12%-33.27M | -165.91%-280.08M | 203.58%424.95M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |